TY - JOUR AU - Formenti, S. C. AU - Demaria, S. PY - 2009 DA - 2009// TI - Systemic effects of local radiotherapy JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70082-8 DO - 10.1016/S1470-2045(09)70082-8 ID - Formenti2009 ER - TY - JOUR AU - Mole, R. H. PY - 1953 DA - 1953// TI - Whole body irradiation; radiobiology or medicine? JO - Br J Radiol VL - 26 UR - https://doi.org/10.1259/0007-1285-26-305-234 DO - 10.1259/0007-1285-26-305-234 ID - Mole1953 ER - TY - STD TI - Sharma P, Wagner K, Wolchok JD, Allison JP. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Vol. 11, Nature Reviews Cancer. NIH Public Access; 2011. p. 805–12. ID - ref3 ER - TY - JOUR AU - Balar, A. V. AU - Galsky, M. D. AU - Rosenberg, J. E. AU - Powles, T. AU - Petrylak, D. P. AU - Bellmunt, J. PY - 2017 DA - 2017// TI - Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)32455-2 DO - 10.1016/S0140-6736(16)32455-2 ID - Balar2017 ER - TY - JOUR AU - Fehrenbacher, L. AU - Spira, A. AU - Ballinger, M. AU - Kowanetz, M. AU - Vansteenkiste, J. AU - Mazieres, J. PY - 2016 DA - 2016// TI - Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(16)00587-0 DO - 10.1016/S0140-6736(16)00587-0 ID - Fehrenbacher2016 ER - TY - JOUR AU - Powles, T. AU - O’Donnell, P. H. AU - Massard, C. AU - Arkenau, H. T. AU - Friedlander, T. W. AU - Hoimes, C. J. PY - 2017 DA - 2017// TI - Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: Updated results from a phase 1/2 open-label study JO - JAMA Oncol. VL - 3 UR - https://doi.org/10.1001/jamaoncol.2017.2411 DO - 10.1001/jamaoncol.2017.2411 ID - Powles2017 ER - TY - JOUR AU - Golden, E. B. AU - Demaria, S. AU - Schiff, P. B. AU - Chachoua, A. AU - Formenti, S. C. PY - 2013 DA - 2013// TI - An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0115 DO - 10.1158/2326-6066.CIR-13-0115 ID - Golden2013 ER - TY - JOUR AU - Grimaldi, A. M. AU - Simeone, E. AU - Giannarelli, D. AU - Muto, P. AU - Falivene, S. AU - Borzillo, V. PY - 2014 DA - 2014// TI - Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy JO - Oncoimmunology. VL - 3 UR - https://doi.org/10.4161/onci.28780 DO - 10.4161/onci.28780 ID - Grimaldi2014 ER - TY - JOUR AU - Qin, Q. AU - Nan, X. AU - Miller, T. AU - Fisher, R. AU - Teh, B. AU - Pandita, S. PY - 2018 DA - 2018// TI - Complete local and abscopal responses from a combination of radiation and nivolumab in refractory Hodgkin’s lymphoma JO - Radiat Res VL - 190 UR - https://doi.org/10.1667/RR15048.1 DO - 10.1667/RR15048.1 ID - Qin2018 ER - TY - JOUR AU - Dewan, M. Z. AU - Galloway, A. E. AU - Kawashima, N. AU - Dewyngaert, J. K. AU - Babb, J. S. AU - Formenti, S. C. PY - 2009 DA - 2009// TI - Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0265 DO - 10.1158/1078-0432.CCR-09-0265 ID - Dewan2009 ER - TY - JOUR AU - Dagoglu, N. AU - Karaman, S. AU - Caglar, H. B. AU - Oral, E. N. PY - 2019 DA - 2019// TI - Abscopal effect of radiotherapy in the immunotherapy era: systematic review of reported cases JO - Cureus. VL - 11 ID - Dagoglu2019 ER - TY - JOUR AU - Dovedi, S. J. AU - Melis, M. H. M. AU - Wilkinson, R. W. AU - Adlard, A. L. AU - Stratford, I. J. AU - Honeychurch, J. PY - 2013 DA - 2013// TI - Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-05-432393 DO - 10.1182/blood-2012-05-432393 ID - Dovedi2013 ER - TY - JOUR AU - Dovedi, S. J. AU - Adlard, A. L. AU - Lipowska-Bhalla, G. AU - McKenna, C. AU - Jones, S. AU - Cheadle, E. J. PY - 2014 DA - 2014// TI - Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-1258 DO - 10.1158/0008-5472.CAN-14-1258 ID - Dovedi2014 ER - TY - JOUR AU - Deng, L. AU - Liang, H. AU - Burnette, B. AU - Beckett, M. AU - Darga, T. AU - Weichselbaum, R. R. PY - 2014 DA - 2014// TI - Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI67313 DO - 10.1172/JCI67313 ID - Deng2014 ER - TY - JOUR AU - Demaria, S. AU - Kawashima, N. AU - Yang, A. M. AU - Devitt, M. L. AU - Babb, J. S. AU - Allison, J. P. PY - 2005 DA - 2005// TI - Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer JO - Clin Cancer Res. VL - 11 ID - Demaria2005 ER - TY - JOUR AU - Formenti, S. C. AU - Rudqvist, N. P. AU - Golden, E. AU - Cooper, B. AU - Wennerberg, E. AU - Lhuillier, C. PY - 2018 DA - 2018// TI - Radiotherapy induces responses of lung cancer to CTLA-4 blockade JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0232-2 DO - 10.1038/s41591-018-0232-2 ID - Formenti2018 ER - TY - JOUR AU - Voorwerk, L. AU - Slagter, M. AU - Horlings, H. M. AU - Sikorska, K. AU - Vijver, K. K. AU - Maaker, M. PY - 2019 DA - 2019// TI - Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial JO - Nat Med VL - 25 UR - https://doi.org/10.1038/s41591-019-0432-4 DO - 10.1038/s41591-019-0432-4 ID - Voorwerk2019 ER - TY - JOUR AU - Weber, R. AU - Fleming, V. AU - Hu, X. AU - Nagibin, V. AU - Groth, C. AU - Altevogt, P. PY - 2018 DA - 2018// TI - Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.01310 DO - 10.3389/fimmu.2018.01310 ID - Weber2018 ER - TY - JOUR AU - Meyer, C. AU - Cagnon, L. AU - Costa-Nunes, C. M. AU - Baumgaertner, P. AU - Montandon, N. AU - Leyvraz, L. PY - 2014 DA - 2014// TI - Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-013-1508-5 DO - 10.1007/s00262-013-1508-5 ID - Meyer2014 ER - TY - JOUR AU - Simeone, E. AU - Gentilcore, G. AU - Giannarelli, D. AU - Grimaldi, A. M. AU - Caracò, C. AU - Curvietto, M. PY - 2014 DA - 2014// TI - Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma JO - Cancer Immunol Immunother VL - 63 UR - https://doi.org/10.1007/s00262-014-1545-8 DO - 10.1007/s00262-014-1545-8 ID - Simeone2014 ER - TY - JOUR AU - Ji, R. R. AU - Chasalow, S. D. AU - Wang, L. AU - Hamid, O. AU - Schmidt, H. AU - Cogswell, J. PY - 2012 DA - 2012// TI - An immune-active tumor microenvironment favors clinical response to ipilimumab JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1172-6 DO - 10.1007/s00262-011-1172-6 ID - Ji2012 ER - TY - JOUR AU - Gough, M. J. AU - Young, K. AU - Crittenden, M. PY - 2013 DA - 2013// TI - The impact of the myeloid response to radiation therapy JO - Clin Dev Immunol. VL - 2013 UR - https://doi.org/10.1155/2013/281958 DO - 10.1155/2013/281958 ID - Gough2013 ER - TY - JOUR AU - Vonderheide, R. H. AU - Glennie, M. J. PY - 2013 DA - 2013// TI - Agonistic CD40 antibodies and cancer therapy JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2064 DO - 10.1158/1078-0432.CCR-12-2064 ID - Vonderheide2013 ER - TY - JOUR AU - Lee, Y. AU - Auh, S. L. AU - Wang, Y. AU - Burnette, B. AU - Wang, Y. AU - Meng, Y. PY - 2009 DA - 2009// TI - Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-02-206870 DO - 10.1182/blood-2009-02-206870 ID - Lee2009 ER - TY - JOUR AU - Kroemer, G. AU - Galluzzi, L. AU - Kepp, O. AU - Zitvogel, L. PY - 2013 DA - 2013// TI - Immunogenic cell death in cancer therapy JO - Annu Rev Immunol VL - 31 UR - https://doi.org/10.1146/annurev-immunol-032712-100008 DO - 10.1146/annurev-immunol-032712-100008 ID - Kroemer2013 ER - TY - JOUR AU - Golden, E. B. AU - Frances, D. AU - Pellicciotta, I. AU - Demaria, S. AU - Barcellos-Hoff, M. H. AU - Formenti, S. C. PY - 2014 DA - 2014// TI - Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death JO - Oncoimmunology. VL - 3 UR - https://doi.org/10.4161/onci.28518 DO - 10.4161/onci.28518 ID - Golden2014 ER - TY - JOUR AU - Apetoh, L. AU - Ghiringhelli, F. AU - Tesniere, A. AU - Obeid, M. AU - Ortiz, C. AU - Criollo, A. PY - 2007 DA - 2007// TI - Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1622 DO - 10.1038/nm1622 ID - Apetoh2007 ER - TY - JOUR AU - Obeid, M. AU - Tesniere, A. AU - Ghiringhelli, F. AU - Fimia, G. M. AU - Apetoh, L. AU - Perfettini, J. L. PY - 2007 DA - 2007// TI - Calreticulin exposure dictates the immunogenicity of cancer cell death JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1523 DO - 10.1038/nm1523 ID - Obeid2007 ER - TY - JOUR AU - Dovedi, S. J. AU - Lipowska-Bhalla, G. AU - Beers, S. A. AU - Cheadle, E. J. AU - Mu, L. AU - Glennie, M. J. PY - 2016 DA - 2016// TI - Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector cd8 T cells JO - Cancer Immunol Res VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-15-0253 DO - 10.1158/2326-6066.CIR-15-0253 ID - Dovedi2016 ER - TY - JOUR AU - Deng, L. AU - Liang, H. AU - Xu, M. AU - Yang, X. AU - Burnette, B. AU - Arina, A. PY - 2014 DA - 2014// TI - STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors JO - Immunity VL - 41 UR - https://doi.org/10.1016/j.immuni.2014.10.019 DO - 10.1016/j.immuni.2014.10.019 ID - Deng2014 ER - TY - JOUR AU - McLaughlin, M. AU - Patin, E. C. AU - Pedersen, M. AU - Wilkins, A. AU - Dillon, M. T. AU - Melcher, A. A. PY - 2020 DA - 2020// TI - Inflammatory microenvironment remodelling by tumour cells after radiotherapy JO - Nat Rev Cancer VL - 20 UR - https://doi.org/10.1038/s41568-020-0246-1 DO - 10.1038/s41568-020-0246-1 ID - McLaughlin2020 ER - TY - JOUR AU - Burnette, B. C. AU - Liang, H. AU - Lee, Y. AU - Chlewicki, L. AU - Khodarev, N. N. AU - Weichselbaum, R. R. PY - 2011 DA - 2011// TI - The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-2820 DO - 10.1158/0008-5472.CAN-10-2820 ID - Burnette2011 ER - TY - JOUR AU - Vanpouille-Box, C. AU - Alard, A. AU - Aryankalayil, M. J. AU - Sarfraz, Y. AU - Diamond, J. M. AU - Schneider, R. J. PY - 2017 DA - 2017// TI - DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms15618 DO - 10.1038/ncomms15618 ID - Vanpouille-Box2017 ER - TY - JOUR AU - MacKenzie, K. J. AU - Carroll, P. AU - Martin, C. A. AU - Murina, O. AU - Fluteau, A. AU - Simpson, D. J. PY - 2017 DA - 2017// TI - CGAS surveillance of micronuclei links genome instability to innate immunity JO - Nature VL - 548 UR - https://doi.org/10.1038/nature23449 DO - 10.1038/nature23449 ID - MacKenzie2017 ER - TY - JOUR AU - Jiao, S. AU - Xia, W. AU - Yamaguchi, H. AU - Wei, Y. AU - Chen, M. K. AU - Hsu, J. M. PY - 2017 DA - 2017// TI - PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-3215 DO - 10.1158/1078-0432.CCR-16-3215 ID - Jiao2017 ER - TY - JOUR AU - Sen, T. AU - Rodriguez, B. L. AU - Chen, L. AU - Della Corte, C. M. AU - Morikawa, N. AU - Fujimoto, J. PY - 2019 DA - 2019// TI - Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer JO - Cancer Discov VL - 9 UR - https://doi.org/10.1158/2159-8290.CD-18-1020 DO - 10.1158/2159-8290.CD-18-1020 ID - Sen2019 ER - TY - JOUR AU - Dillon, M. T. AU - Boylan, Z. AU - Smith, D. AU - Guevara, J. AU - Mohammed, K. AU - Peckitt, C. PY - 2018 DA - 2018// TI - PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid JO - Clin Transl Radiat Oncol VL - 12 UR - https://doi.org/10.1016/j.ctro.2018.06.001 DO - 10.1016/j.ctro.2018.06.001 ID - Dillon2018 ER - TY - JOUR AU - Fulton, B. AU - Short, S. C. AU - James, A. AU - Nowicki, S. AU - McBain, C. AU - Jefferies, S. PY - 2018 DA - 2018// TI - PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status JO - Clin Transl Radiat Oncol VL - 8 UR - https://doi.org/10.1016/j.ctro.2017.11.003 DO - 10.1016/j.ctro.2017.11.003 ID - Fulton2018 ER - TY - JOUR AU - Ma, Y. AU - Vassetzky, Y. AU - Dokudovskaya, S. PY - 2018 DA - 2018// TI - mTORC1 pathway in DNA damage response JO - Biochim Biophys Acta - Mol Cell Res VL - 1865 UR - https://doi.org/10.1016/j.bbamcr.2018.06.011 DO - 10.1016/j.bbamcr.2018.06.011 ID - Ma2018 ER - TY - JOUR AU - Reits, E. A. AU - Hodge, J. W. AU - Herberts, C. A. AU - Groothuis, T. A. AU - Chakraborty, M. AU - Wansley, E. K. PY - 2006 DA - 2006// TI - Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy JO - J Exp Med VL - 203 UR - https://doi.org/10.1084/jem.20052494 DO - 10.1084/jem.20052494 ID - Reits2006 ER - TY - JOUR AU - Lugade, A. A. AU - Sorensen, E. W. AU - Gerber, S. A. AU - Moran, J. P. AU - Frelinger, J. G. AU - Lord, E. M. PY - 2008 DA - 2008// TI - Radiation-induced IFN-γ production within the tumor microenvironment influences antitumor immunity JO - J Immunol VL - 180 UR - https://doi.org/10.4049/jimmunol.180.5.3132 DO - 10.4049/jimmunol.180.5.3132 ID - Lugade2008 ER - TY - JOUR AU - Chakraborty, M. AU - Abrams, S. I. AU - Camphausen, K. AU - Liu, K. AU - Scott, T. AU - Coleman, C. N. PY - 2003 DA - 2003// TI - Irradiation of tumor cells up-regulates fas and enhances CTL lytic activity and CTL adoptive immunotherapy JO - J Immunol VL - 170 UR - https://doi.org/10.4049/jimmunol.170.12.6338 DO - 10.4049/jimmunol.170.12.6338 ID - Chakraborty2003 ER - TY - JOUR AU - Vanpouille-Box, C. AU - Pilones, K. A. AU - Wennerberg, E. AU - Formenti, S. C. AU - Demaria, S. PY - 2015 DA - 2015// TI - In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment JO - Vaccine VL - 33 UR - https://doi.org/10.1016/j.vaccine.2015.05.105 DO - 10.1016/j.vaccine.2015.05.105 ID - Vanpouille-Box2015 ER - TY - JOUR AU - Demaria, S. AU - Ng, B. AU - Devitt, M. L. AU - Babb, J. S. AU - Kawashima, N. AU - Liebes, L. PY - 2004 DA - 2004// TI - Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated JO - Int J Radiat Oncol Biol Phys VL - 58 UR - https://doi.org/10.1016/j.ijrobp.2003.09.012 DO - 10.1016/j.ijrobp.2003.09.012 ID - Demaria2004 ER - TY - JOUR AU - Dovedi, S. J. AU - Cheadle, E. J. AU - Popple, A. L. AU - Poon, E. AU - Morrow, M. AU - Stewart, R. PY - 2017 DA - 2017// TI - Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1673 DO - 10.1158/1078-0432.CCR-16-1673 ID - Dovedi2017 ER - TY - JOUR AU - Matsumura, S. AU - Wang, B. AU - Kawashima, N. AU - Braunstein, S. AU - Badura, M. AU - Cameron, T. O. PY - 2008 DA - 2008// TI - Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.5.3099 DO - 10.4049/jimmunol.181.5.3099 ID - Matsumura2008 ER - TY - JOUR AU - Spranger, S. AU - Dai, D. AU - Horton, B. AU - Gajewski, T. F. PY - 2017 DA - 2017// TI - Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy JO - Cancer Cell VL - 31 UR - https://doi.org/10.1016/j.ccell.2017.04.003 DO - 10.1016/j.ccell.2017.04.003 ID - Spranger2017 ER - TY - JOUR AU - Riegler, J. AU - Gill, H. AU - Ogasawara, A. AU - Hedehus, M. AU - Javinal, V. AU - Oeh, J. PY - 2019 DA - 2019// TI - VCAM-1 density and tumor perfusion predict T-cell infiltration and treatment response in preclinical models JO - Neoplasia (US) VL - 21 UR - https://doi.org/10.1016/j.neo.2019.08.003 DO - 10.1016/j.neo.2019.08.003 ID - Riegler2019 ER - TY - JOUR AU - Marciscano, A. E. AU - Ghasemzadeh, A. AU - Nirschl, T. R. AU - Theodros, D. AU - Kochel, C. M. AU - Francica, B. J. PY - 2018 DA - 2018// TI - Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-17-3427 DO - 10.1158/1078-0432.CCR-17-3427 ID - Marciscano2018 ER - TY - JOUR AU - Honeychurch, J. AU - Glennie, M. J. AU - Johnson, P. W. M. AU - Illidge, T. M. PY - 2003 DA - 2003// TI - Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2002-12-3717 DO - 10.1182/blood-2002-12-3717 ID - Honeychurch2003 ER - TY - JOUR AU - Sonpavde, G. AU - McMannis, J. D. AU - Bai, Y. AU - Seethammagari, M. R. AU - Bull, J. M. C. AU - Hawkins, V. PY - 2017 DA - 2017// TI - Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer JO - Cancer Immunol Immunother VL - 66 UR - https://doi.org/10.1007/s00262-017-2027-6 DO - 10.1007/s00262-017-2027-6 ID - Sonpavde2017 ER - TY - JOUR AU - Rech, A. J. AU - Dada, H. AU - Kotzin, J. J. AU - Henao-Mejia, J. AU - Minn, A. J. AU - Victor, C. T. PY - 2018 DA - 2018// TI - Radiotherapy and CD40 activation separately augment immunity to checkpoint blockade in cancer JO - Cancer Res. VL - 78 UR - https://doi.org/10.1158/0008-5472.CAN-17-3821 DO - 10.1158/0008-5472.CAN-17-3821 ID - Rech2018 ER - TY - JOUR AU - Djenidi, F. AU - Adam, J. AU - Goubar, A. AU - Durgeau, A. AU - Meurice, G. AU - Montpréville, V. PY - 2015 DA - 2015// TI - CD8+ CD103 + tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients JO - J Immunol VL - 194 UR - https://doi.org/10.4049/jimmunol.1402711 DO - 10.4049/jimmunol.1402711 ID - Djenidi2015 ER - TY - JOUR AU - Webb, J. R. AU - Milne, K. AU - Watson, P. AU - DeLeeuw, R. J. AU - Nelson, B. H. PY - 2014 DA - 2014// TI - Tumor-infiltrating lymphocytes expressing the tissue resident memory marker cd103 are associated with increased survival in high-grade serous ovarian cancer JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-1877 DO - 10.1158/1078-0432.CCR-13-1877 ID - Webb2014 ER - TY - JOUR AU - Enamorado, M. AU - Iborra, S. AU - Priego, E. AU - Cueto, F. J. AU - Quintana, J. A. AU - Martýnez-Cano, S. PY - 2017 DA - 2017// TI - Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms16073 DO - 10.1038/ncomms16073 ID - Enamorado2017 ER - TY - JOUR AU - Caetano, M. S. AU - Younes, A. I. AU - Barsoumian, H. B. AU - Quigley, M. AU - Menon, H. AU - Gao, C. PY - 2019 DA - 2019// TI - Triple therapy with MeRTK and PD1 inhibition plus radiotherapy promotes abscopal antitumor immune responses JO - Clin Cancer Res VL - 25 UR - https://doi.org/10.1158/1078-0432.CCR-19-0795 DO - 10.1158/1078-0432.CCR-19-0795 ID - Caetano2019 ER - TY - JOUR AU - Deng, L. AU - Liang, H. AU - Burnette, B. AU - Weichselbaum, R. R. AU - Fu, Y. X. PY - 2014 DA - 2014// TI - Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression JO - Oncoimmunology. VL - 3 UR - https://doi.org/10.4161/onci.28499 DO - 10.4161/onci.28499 ID - Deng2014 ER - TY - JOUR AU - Marigo, I. AU - Dolcetti, L. AU - Serafini, P. AU - Zanovello, P. AU - Bronte, V. PY - 2008 DA - 2008// TI - Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells JO - Immunol Rev VL - 222 UR - https://doi.org/10.1111/j.1600-065X.2008.00602.x DO - 10.1111/j.1600-065X.2008.00602.x ID - Marigo2008 ER - TY - JOUR AU - Wang, D. AU - An, G. AU - Xie, S. AU - Yao, Y. AU - Feng, G. PY - 2016 DA - 2016// TI - The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy JO - Tumor Biol VL - 37 UR - https://doi.org/10.1007/s13277-016-4916-2 DO - 10.1007/s13277-016-4916-2 ID - Wang2016 ER - TY - JOUR AU - Fridman, W. H. AU - Zitvogel, L. AU - Sautès-Fridman, C. AU - Kroemer, G. PY - 2017 DA - 2017// TI - The immune contexture in cancer prognosis and treatment JO - Nat Rev Clin Oncol VL - 14 UR - https://doi.org/10.1038/nrclinonc.2017.101 DO - 10.1038/nrclinonc.2017.101 ID - Fridman2017 ER - TY - JOUR AU - Vatner, R. E. AU - Formenti, S. C. PY - 2015 DA - 2015// TI - Myeloid-derived cells in tumors: effects of radiation JO - Semin Radiat Oncol VL - 25 UR - https://doi.org/10.1016/j.semradonc.2014.07.008 DO - 10.1016/j.semradonc.2014.07.008 ID - Vatner2015 ER - TY - JOUR AU - Kachikwu, E. L. AU - Iwamoto, K. S. AU - Liao, Y. P. AU - Demarco, J. J. AU - Agazaryan, N. AU - Economou, J. S. PY - 2011 DA - 2011// TI - Radiation enhances regulatory T cell representation JO - Int J Radiat Oncol Biol Phys VL - 81 UR - https://doi.org/10.1016/j.ijrobp.2010.09.034 DO - 10.1016/j.ijrobp.2010.09.034 ID - Kachikwu2011 ER - TY - JOUR AU - Shojaei, F. AU - Zhong, C. AU - Wu, X. AU - Yu, L. AU - Ferrara, N. PY - 2008 DA - 2008// TI - Role of myeloid cells in tumor angiogenesis and growth JO - Trends Cell Biol VL - 18 UR - https://doi.org/10.1016/j.tcb.2008.06.003 DO - 10.1016/j.tcb.2008.06.003 ID - Shojaei2008 ER - TY - JOUR AU - Ahn, G. O. AU - Brown, J. M. PY - 2008 DA - 2008// TI - Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells JO - Cancer Cell VL - 13 UR - https://doi.org/10.1016/j.ccr.2007.11.032 DO - 10.1016/j.ccr.2007.11.032 ID - Ahn2008 ER - TY - JOUR AU - Togashi, Y. AU - Shitara, K. AU - Nishikawa, H. PY - 2019 DA - 2019// TI - Regulatory T cells in cancer immunosuppression—implications for anticancer therapy JO - Nat Rev Clin Oncol VL - 16 UR - https://doi.org/10.1038/s41571-019-0175-7 DO - 10.1038/s41571-019-0175-7 ID - Togashi2019 ER - TY - JOUR AU - Liyanage, U. K. AU - Moore, T. T. AU - Joo, H. -. G. AU - Tanaka, Y. AU - Herrmann, V. AU - Doherty, G. PY - 2002 DA - 2002// TI - Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma JO - J Immunol VL - 169 UR - https://doi.org/10.4049/jimmunol.169.5.2756 DO - 10.4049/jimmunol.169.5.2756 ID - Liyanage2002 ER - TY - JOUR AU - Allavena, P. AU - Sica, A. AU - Garlanda, C. AU - Mantovani, A. PY - 2008 DA - 2008// TI - The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance JO - Immunol Rev VL - 222 UR - https://doi.org/10.1111/j.1600-065X.2008.00607.x DO - 10.1111/j.1600-065X.2008.00607.x ID - Allavena2008 ER - TY - JOUR AU - Vinay, D. S. AU - Ryan, E. P. AU - Pawelec, G. AU - Talib, W. H. AU - Stagg, J. AU - Elkord, E. PY - 2015 DA - 2015// TI - Immune evasion in cancer: mechanistic basis and therapeutic strategies JO - Semin Cancer Biol VL - 35 UR - https://doi.org/10.1016/j.semcancer.2015.03.004 DO - 10.1016/j.semcancer.2015.03.004 ID - Vinay2015 ER - TY - JOUR AU - Liang, H. AU - Deng, L. AU - Hou, Y. AU - Meng, X. AU - Huang, X. AU - Rao, E. PY - 2017 DA - 2017// TI - Host STING-dependent MDSC mobilization drives extrinsic radiation resistance JO - Nat Commun. VL - 8 UR - https://doi.org/10.1038/s41467-017-01566-5 DO - 10.1038/s41467-017-01566-5 ID - Liang2017 ER - TY - JOUR AU - Yang, L. AU - Pang, Y. AU - Moses, H. L. PY - 2010 DA - 2010// TI - TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression JO - Trends Immunol VL - 31 UR - https://doi.org/10.1016/j.it.2010.04.002 DO - 10.1016/j.it.2010.04.002 ID - Yang2010 ER - TY - JOUR AU - Vanpouille-Box, C. AU - Diamond, J. M. AU - Pilones, K. A. AU - Zavadil, J. AU - Babb, J. S. AU - Formenti, S. C. PY - 2015 DA - 2015// TI - TGFβ is a master regulator of radiation therapy-induced antitumor immunity JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-3511 DO - 10.1158/0008-5472.CAN-14-3511 ID - Vanpouille-Box2015 ER - TY - JOUR AU - Calon, A. AU - Espinet, E. AU - Palomo-Ponce, S. AU - Tauriello, D. V. F. AU - Iglesias, M. AU - Céspedes, M. V. PY - 2012 DA - 2012// TI - Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation JO - Cancer Cell VL - 22 UR - https://doi.org/10.1016/j.ccr.2012.08.013 DO - 10.1016/j.ccr.2012.08.013 ID - Calon2012 ER - TY - JOUR AU - Sow, H. AU - Ren, J. AU - Camps, M. AU - Ossendorp, F. AU - Dijke, P. PY - 2019 DA - 2019// TI - Combined inhibition of TGF-β signaling and the PD-L1 immune checkpoint is differentially effective in tumor models JO - Cells VL - 8 UR - https://doi.org/10.3390/cells8040320 DO - 10.3390/cells8040320 ID - Sow2019 ER - TY - JOUR AU - Connolly, K. A. AU - Belt, B. A. AU - Figueroa, N. M. AU - Murthy, A. AU - Patel, A. AU - Kim, M. PY - 2016 DA - 2016// TI - Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.13287 DO - 10.18632/oncotarget.13287 ID - Connolly2016 ER - TY - JOUR AU - Nywening, T. M. AU - Wang-Gillam, A. AU - Sanford, D. E. AU - Belt, B. A. AU - Panni, R. Z. AU - Cusworth, B. M. PY - 2016 DA - 2016// TI - Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: A single-centre, open-label, dose-finding, non-randomised, phase 1b trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)00078-4 DO - 10.1016/S1470-2045(16)00078-4 ID - Nywening2016 ER - TY - JOUR AU - Qian, B. Z. AU - Li, J. AU - Zhang, H. AU - Kitamura, T. AU - Zhang, J. AU - Campion, L. R. PY - 2011 DA - 2011// TI - CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis JO - Nature VL - 475 UR - https://doi.org/10.1038/nature10138 DO - 10.1038/nature10138 ID - Qian2011 ER - TY - JOUR AU - Gebhardt, C. AU - Sevko, A. AU - Jiang, H. AU - Lichtenberger, R. AU - Reith, M. AU - Tarnanidis, K. PY - 2015 DA - 2015// TI - Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-15-0676 DO - 10.1158/1078-0432.CCR-15-0676 ID - Gebhardt2015 ER - TY - JOUR AU - Limagne, E. AU - Euvrard, R. AU - Thibaudin, M. AU - Rébé, C. AU - Derangère, V. AU - Chevriaux, A. PY - 2016 DA - 2016// TI - Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predicts the efficacy of a FOLFOX-bevacizumab drug treatment regimen JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-3164 DO - 10.1158/0008-5472.CAN-15-3164 ID - Limagne2016 ER - TY - JOUR AU - Hansen, G. L. AU - Gaudernack, G. AU - Brunsvig, P. F. AU - Cvancarova, M. AU - Kyte, J. A. PY - 2015 DA - 2015// TI - Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination JO - Cancer Immunol Immunother VL - 64 UR - https://doi.org/10.1007/s00262-015-1766-5 DO - 10.1007/s00262-015-1766-5 ID - Hansen2015 ER - TY - JOUR AU - Finkelstein, S. E. AU - Iclozan, C. AU - Bui, M. M. AU - Cotter, M. J. AU - Ramakrishnan, R. AU - Ahmed, J. PY - 2012 DA - 2012// TI - Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2010.12.068 DO - 10.1016/j.ijrobp.2010.12.068 ID - Finkelstein2012 ER - TY - JOUR AU - Buhtoiarov, I. N. AU - Lum, H. AU - Berke, G. AU - Paulnock, D. M. AU - Sondel, P. M. AU - Rakhmilevich, A. L. PY - 2005 DA - 2005// TI - CD40 ligation activates murine macrophages via an IFN-γ-dependent mechanism resulting in tumor cell destruction in vitro JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.10.6013 DO - 10.4049/jimmunol.174.10.6013 ID - Buhtoiarov2005 ER - TY - JOUR AU - Crittenden, M. R. AU - Baird, J. AU - Friedman, D. AU - Savage, T. AU - Uhde, L. AU - Alice, A. PY - 2016 DA - 2016// TI - Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.11823 DO - 10.18632/oncotarget.11823 ID - Crittenden2016 ER - TY - JOUR AU - Pasare, C. AU - Medzhitov, R. PY - 2003 DA - 2003// TI - Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells JO - Science VL - 299 UR - https://doi.org/10.1126/science.1078231 DO - 10.1126/science.1078231 ID - Pasare2003 ER - TY - STD TI - Kobold S, Wiedemann G, Rothenfußer S, Endres S. Modes of action of TLR7 agonists in cancer therapy. Vol. 6, Immunotherapy. Future Medicine Ltd.; 2014. p. 1085–95. ID - ref84 ER - TY - JOUR AU - Wang, J. AU - Shirota, Y. AU - Bayik, D. AU - Shirota, H. AU - Tross, D. AU - Gulley, J. L. PY - 2015 DA - 2015// TI - Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells JO - J Immunol VL - 194 UR - https://doi.org/10.4049/jimmunol.1402004 DO - 10.4049/jimmunol.1402004 ID - Wang2015 ER - TY - JOUR AU - Spinetti, T. AU - Spagnuolo, L. AU - Mottas, I. AU - Secondini, C. AU - Treinies, M. AU - Rüegg, C. PY - 2016 DA - 2016// TI - TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1230578 DO - 10.1080/2162402X.2016.1230578 ID - Spinetti2016 ER - TY - JOUR AU - Shime, H. AU - Matsumoto, M. AU - Oshiumi, H. AU - Tanaka, S. AU - Nakane, A. AU - Iwakura, Y. PY - 2012 DA - 2012// TI - Toll-like receptor 3 signaling converts tumorsupporting myeloid cells to tumoricidal effectors JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1113099109 DO - 10.1073/pnas.1113099109 ID - Shime2012 ER - TY - JOUR AU - Dovedi, S. J. AU - Adlard, A. L. AU - Ota, Y. AU - Murata, M. AU - Sugaru, E. AU - Koga-Yamakawa, E. PY - 2016 DA - 2016// TI - Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7928 DO - 10.18632/oncotarget.7928 ID - Dovedi2016 ER - TY - JOUR AU - Schölch, S. AU - Rauber, C. AU - Tietz, A. AU - Rahbari, N. N. AU - Bork, U. AU - Schmidt, T. PY - 2015 DA - 2015// TI - Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3081 DO - 10.18632/oncotarget.3081 ID - Schölch2015 ER - TY - JOUR AU - Dewan, M. Z. AU - Vanpouille-Box, C. AU - Kawashima, N. AU - DiNapoli, S. AU - Babb, J. S. AU - Formenti, S. C. PY - 2012 DA - 2012// TI - Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0984 DO - 10.1158/1078-0432.CCR-12-0984 ID - Dewan2012 ER - TY - JOUR AU - Mariathasan, S. AU - Turley, S. J. AU - Nickles, D. AU - Castiglioni, A. AU - Yuen, K. AU - Wang, Y. PY - 2018 DA - 2018// TI - TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells JO - Nature VL - 554 UR - https://doi.org/10.1038/nature25501 DO - 10.1038/nature25501 ID - Mariathasan2018 ER - TY - JOUR AU - Tauriello, D. V. F. AU - Palomo-Ponce, S. AU - Stork, D. AU - Berenguer-Llergo, A. AU - Badia-Ramentol, J. AU - Iglesias, M. PY - 2018 DA - 2018// TI - TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis JO - Nature VL - 554 UR - https://doi.org/10.1038/nature25492 DO - 10.1038/nature25492 ID - Tauriello2018 ER - TY - JOUR AU - Rodríguez-Ruiz, M. E. AU - Rodríguez, I. AU - Mayorga, L. AU - Labiano, T. AU - Barbes, B. AU - Etxeberria, I. PY - 2019 DA - 2019// TI - TGFb blockade enhances radiotherapy abscopal efficacy effects in combination with anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies JO - Mol Cancer Ther VL - 18 UR - https://doi.org/10.1158/1535-7163.MCT-18-0558 DO - 10.1158/1535-7163.MCT-18-0558 ID - Rodríguez-Ruiz2019 ER - TY - JOUR AU - Garrison, K. AU - Hahn, T. AU - Lee, W. C. AU - Ling, L. E. AU - Weinberg, A. D. AU - Akporiaye, E. T. PY - 2012 DA - 2012// TI - The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1119-y DO - 10.1007/s00262-011-1119-y ID - Garrison2012 ER - TY - JOUR AU - Strauss, J. AU - Heery, C. R. AU - Schlom, J. AU - Madan, R. A. AU - Cao, L. AU - Kang, Z. PY - 2018 DA - 2018// TI - Phase I trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGFb, in advanced solid tumors JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-17-2653 DO - 10.1158/1078-0432.CCR-17-2653 ID - Strauss2018 ER - TY - JOUR AU - Dahmani, A. AU - Delisle, J. S. PY - 2018 DA - 2018// TI - TGF-β in T cell biology: Implications for cancer immunotherapy JO - Cancers (Basel) VL - 10 UR - https://doi.org/10.3390/cancers10060194 DO - 10.3390/cancers10060194 ID - Dahmani2018 ER - TY - JOUR AU - Serafini, P. AU - Meckel, K. AU - Kelso, M. AU - Noonan, K. AU - Califano, J. AU - Koch, W. PY - 2006 DA - 2006// TI - Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function JO - J Exp Med VL - 203 UR - https://doi.org/10.1084/jem.20061104 DO - 10.1084/jem.20061104 ID - Serafini2006 ER - TY - JOUR AU - Hassel, J. C. AU - Jiang, H. AU - Bender, C. AU - Winkler, J. AU - Sevko, A. AU - Shevchenko, I. PY - 2017 DA - 2017// TI - Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe) JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1326440 DO - 10.1080/2162402X.2017.1326440 ID - Hassel2017 ER - TY - JOUR AU - Horsman, M. R. AU - Overgaard, J. PY - 2016 DA - 2016// TI - The impact of hypoxia and its modification of the outcome of radiotherapy significance of hypoxia JO - J Radiat Res VL - 57 UR - https://doi.org/10.1093/jrr/rrw007 DO - 10.1093/jrr/rrw007 ID - Horsman2016 ER - TY - JOUR AU - Chen, F. H. AU - Chiang, C. S. AU - Wang, C. C. AU - Tsai, C. S. AU - Jung, S. M. AU - Lee, C. C. PY - 2009 DA - 2009// TI - Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1471 DO - 10.1158/1078-0432.CCR-08-1471 ID - Chen2009 ER - TY - JOUR AU - Tsai, J. H. AU - Makonnen, S. AU - Feldman, M. AU - Sehgal, C. M. AU - Maity, A. AU - Lee, W. M. F. PY - 2005 DA - 2005// TI - Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis JO - Cancer Biol Ther VL - 4 UR - https://doi.org/10.4161/cbt.4.12.2331 DO - 10.4161/cbt.4.12.2331 ID - Tsai2005 ER - TY - JOUR AU - Tsai, C. S. AU - Chen, F. H. AU - Wang, C. C. AU - Huang, H. L. AU - Jung, S. M. AU - Wu, C. J. PY - 2007 DA - 2007// TI - Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth JO - Int J Radiat Oncol Biol Phys VL - 68 UR - https://doi.org/10.1016/j.ijrobp.2007.01.041 DO - 10.1016/j.ijrobp.2007.01.041 ID - Tsai2007 ER - TY - JOUR AU - Moeller, B. J. AU - Cao, Y. AU - Li, C. Y. AU - Dewhirst, M. W. PY - 2004 DA - 2004// TI - Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules JO - Cancer Cell VL - 5 UR - https://doi.org/10.1016/S1535-6108(04)00115-1 DO - 10.1016/S1535-6108(04)00115-1 ID - Moeller2004 ER - TY - JOUR AU - Eckert, F. AU - Zwirner, K. AU - Boeke, S. AU - Thorwarth, D. AU - Zips, D. AU - Huber, S. M. PY - 2019 DA - 2019// TI - Rationale for combining radiotherapy and immune checkpoint inhibition for patients with hypoxic tumors JO - Front Immunol. VL - 10 UR - https://doi.org/10.3389/fimmu.2019.00407 DO - 10.3389/fimmu.2019.00407 ID - Eckert2019 ER - TY - JOUR AU - Barsoum, I. B. AU - Smallwood, C. A. AU - Siemens, D. R. AU - Graham, C. H. PY - 2014 DA - 2014// TI - A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-0992 DO - 10.1158/0008-5472.CAN-13-0992 ID - Barsoum2014 ER - TY - JOUR AU - Graham, K. AU - Unger, E. PY - 2018 DA - 2018// TI - Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment JO - Int J Nanomed Dovepress. VL - 13 UR - https://doi.org/10.2147/IJN.S140462 DO - 10.2147/IJN.S140462 ID - Graham2018 ER - TY - JOUR AU - Sharabi, A. B. AU - Nirschl, C. J. AU - Kochel, C. M. AU - Nirschl, T. R. AU - Francica, B. J. AU - Velarde, E. PY - 2015 DA - 2015// TI - Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen JO - Cancer Immunol Res VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-14-0196 DO - 10.1158/2326-6066.CIR-14-0196 ID - Sharabi2015 ER - TY - JOUR AU - Patel, K. R. AU - Martinez, A. AU - Stahl, J. M. AU - Logan, S. J. AU - Perricone, A. J. AU - Ferris, M. J. PY - 2018 DA - 2018// TI - Increase in PD-L1 expression after pre-operative radiotherapy for soft tissue sarcoma JO - Oncoimmunology. VL - 7 UR - https://doi.org/10.1080/2162402X.2018.1442168 DO - 10.1080/2162402X.2018.1442168 ID - Patel2018 ER - TY - JOUR AU - Derer, A. AU - Spiljar, M. AU - Bäumler, M. AU - Hecht, M. AU - Fietkau, R. AU - Frey, B. PY - 2016 DA - 2016// TI - Chemoradiation increases PD-L1 expression in certain melanoma and glioblastoma cells JO - Front Immunol. VL - 7 UR - https://doi.org/10.3389/fimmu.2016.00610 DO - 10.3389/fimmu.2016.00610 ID - Derer2016 ER - TY - JOUR AU - Grapin, M. AU - Richard, C. AU - Limagne, E. AU - Boidot, R. AU - Morgand, V. AU - Bertaut, A. PY - 2019 DA - 2019// TI - Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination JO - J Immunother Cancer VL - 7 UR - https://doi.org/10.1186/s40425-019-0634-9 DO - 10.1186/s40425-019-0634-9 ID - Grapin2019 ER - TY - JOUR AU - Arina, A. AU - Beckett, M. AU - Fernandez, C. AU - Zheng, W. AU - Pitroda, S. AU - Chmura, S. J. PY - 2019 DA - 2019// TI - Tumor-reprogrammed resident T cells resist radiation to control tumors JO - Nat Commun. VL - 10 UR - https://doi.org/10.1038/s41467-019-11906-2 DO - 10.1038/s41467-019-11906-2 ID - Arina2019 ER - TY - JOUR AU - Grayson, J. M. AU - Harrington, L. E. AU - Lanier, J. G. AU - Wherry, E. J. AU - Ahmed, R. PY - 2002 DA - 2002// TI - Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo JO - J Immunol VL - 169 UR - https://doi.org/10.4049/jimmunol.169.7.3760 DO - 10.4049/jimmunol.169.7.3760 ID - Grayson2002 ER - TY - JOUR AU - Gerber, S. A. AU - Sedlacek, A. L. AU - Cron, K. R. AU - Murphy, S. P. AU - Frelinger, J. G. AU - Lord, E. M. PY - 2013 DA - 2013// TI - IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor JO - Am J Pathol VL - 182 UR - https://doi.org/10.1016/j.ajpath.2013.02.041 DO - 10.1016/j.ajpath.2013.02.041 ID - Gerber2013 ER - TY - JOUR AU - Zimmerman, M. AU - Yang, D. AU - Hu, X. AU - Liu, F. AU - Singh, N. AU - Browning, D. PY - 2010 DA - 2010// TI - IFN-γ upregulates Survivin and ifi202 expression to induce survival and proliferation of tumor-specific T cells JO - PLoS One. VL - 5 UR - https://doi.org/10.1371/journal.pone.0014076 DO - 10.1371/journal.pone.0014076 ID - Zimmerman2010 ER - TY - JOUR AU - Huang, A. C. AU - Postow, M. A. AU - Orlowski, R. J. AU - Mick, R. AU - Bengsch, B. AU - Manne, S. PY - 2017 DA - 2017// TI - T-cell invigoration to tumour burden ratio associated with anti-PD-1 response JO - Nature VL - 545 UR - https://doi.org/10.1038/nature22079 DO - 10.1038/nature22079 ID - Huang2017 ER - TY - JOUR AU - Luke, J. J. AU - Lemons, J. M. AU - Karrison, T. G. AU - Pitroda, S. P. AU - Melotek, J. M. AU - Zha, Y. PY - 2018 DA - 2018// TI - Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.76.2229 DO - 10.1200/JCO.2017.76.2229 ID - Luke2018 ER - TY - JOUR AU - Antonia, S. J. AU - Villegas, A. AU - Daniel, D. AU - Vicente, D. AU - Murakami, S. AU - Hui, R. PY - 2017 DA - 2017// TI - Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1709937 DO - 10.1056/NEJMoa1709937 ID - Antonia2017 ER - TY - JOUR AU - Antonia, S. J. AU - Villegas, A. AU - Daniel, D. AU - Vicente, D. AU - Murakami, S. AU - Hui, R. PY - 2018 DA - 2018// TI - Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMoa1809697 DO - 10.1056/NEJMoa1809697 ID - Antonia2018 ER - TY - JOUR AU - Lee, V. H. F. AU - Lo, A. W. I. AU - Leung, C. Y. AU - Shek, W. H. AU - Kwong, D. L. W. AU - Lam, K. O. PY - 2016 DA - 2016// TI - Correlation of PD-L1 expression of tumor cells with survival outcomes after radical intensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0157969 DO - 10.1371/journal.pone.0157969 ID - Lee2016 ER - TY - JOUR AU - Iijima, M. AU - Okonogi, N. AU - Nakajima, N. I. AU - Morokoshi, Y. AU - Kanda, H. AU - Yamada, T. PY - 2020 DA - 2020// TI - Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma JO - J Gynecol Oncol. VL - 31 UR - https://doi.org/10.3802/jgo.2020.31.e19 DO - 10.3802/jgo.2020.31.e19 ID - Iijima2020 ER - TY - JOUR AU - Angell, H. AU - Galon, J. PY - 2013 DA - 2013// TI - From the immune contexture to the Immunoscore: The role of prognostic and predictive immune markers in cancer JO - Curr Opin Immunol VL - 25 UR - https://doi.org/10.1016/j.coi.2013.03.004 DO - 10.1016/j.coi.2013.03.004 ID - Angell2013 ER - TY - JOUR AU - Galon, J. AU - Costes, A. AU - Sanchez-Cabo, F. AU - Kirilovsky, A. AU - Mlecnik, B. AU - Lagorce-Pagès, C. PY - 2006 DA - 2006// TI - Type, density, and location of immune cells within human colorectal tumors predict clinical outcome JO - Science VL - 313 UR - https://doi.org/10.1126/science.1129139 DO - 10.1126/science.1129139 ID - Galon2006 ER - TY - JOUR AU - Hagland, H. R. AU - Lea, D. AU - Watson, M. M. C. AU - Søreide, K. PY - 2017 DA - 2017// TI - Correlation of circulating T-cells in pre-operative blood to intratumoral density and location of CD3+ and CD8+ T-cells in colorectal cancer: a potential for an immunoscore by liquid biopsy? JO - Eur J Cancer VL - 72 UR - https://doi.org/10.1016/S0959-8049(17)30242-3 DO - 10.1016/S0959-8049(17)30242-3 ID - Hagland2017 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. AU - Shintaku, I. P. AU - Taylor, E. J. M. AU - Robert, L. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - JOUR AU - Sakuishi, K. AU - Apetoh, L. AU - Sullivan, J. M. AU - Blazar, B. R. AU - Kuchroo, V. K. AU - Anderson, A. C. PY - 2010 DA - 2010// TI - Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20100643 DO - 10.1084/jem.20100643 ID - Sakuishi2010 ER - TY - JOUR AU - Matsuzaki, J. AU - Gnjatic, S. AU - Mhawech-Fauceglia, P. AU - Beck, A. AU - Miller, A. AU - Tsuji, T. PY - 2010 DA - 2010// TI - Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer JO - Proc Natl Acad Sci USA VL - 107 UR - https://doi.org/10.1073/pnas.1003345107 DO - 10.1073/pnas.1003345107 ID - Matsuzaki2010 ER - TY - JOUR AU - Xu, J. AU - Escamilla, J. AU - Mok, S. AU - David, J. AU - Priceman, S. AU - West, B. PY - 2013 DA - 2013// TI - CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-3981 DO - 10.1158/0008-5472.CAN-12-3981 ID - Xu2013 ER -